Modulation of relative intrinsic activity of agonists at the alpha-2A adrenoceptor by mutation of residue 351 of G protein G(i1α)

Molecular Pharmacology

Volumn 55, Issue 2, 1999, Pages 195-201

  Jackson, Vicky N ^a   Bahia, Daljit S ^a   Milligan, Graeme ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; CLONIDINE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PARTIAL AGONIST; YOHIMBINE;

ADRENERGIC ACTIVITY; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

EID: 0032978619     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.55.2.195     Document Type: Article

References (25)

1. 2A-adrenoceptor, Biochemistry 37:11555-11562
2. Bourne H (1997) How receptors talk to trimeric G proteins. Curr Opin Cell Biol 9:134-142.
3. i1α fusion protein results in activation of both receptor- linked and endogenous G proteins: Comparisons of their contributions to GTPase activity and signal transduction and analysis of receptor-G protein activation stoichiometry. J Biol Chem 273:10367-10375.
4. i1α fusion protein activation. FEBS Lett 428:17-22.
5. Chuprun JK, Raymond JR and Blackshear PJ (1997) The heterotrimeric G protein G alpha i2 mediates lysophosphatidic acid-stimulated induction of the c-fos gene in mouse fibroblasts. J Biol Chem 272:773-781.
6. Clarke WP and Bond RA (1998) The elusive nature of intrinsic activity. Trends Pharmacol Sci 19:270-276.
7. +, and amiloride analogs. J Biol Chem 265:17307-17317.
8. Hamm HE (1998) The many faces of G protein signaling. J Biol Chem 273:669-672.
9. Hoyer D and Boddeke HWGM (1993) Partial agonists, full agonists, antagonists: Dilemmas of definition. Trends Pharmacol Sci 14:270-275.
10. Hunt TW, Carroll RC and Peralta EG (1994) Heterotrimeric G proteins containing G alpha i3 regulate multiple effector enzymes in the same cell: Activation of phospholipases C and A2 and inhibition of adenylyl cyclase. J Biol Chem 269: 29565-29570.
11. 35S]GTPgammaS binding. Biochem Pharmacol 55:1035-1043.
12. Lefkowitz RJ, Cotecchia S, Samama P and Costa T (1993) Constitutive activity of receptors coupled to guanine-nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307.
13. Liu J, Conklin BR, Blin N, Yun J and Wess J (1995) Identification of a receptor/ G-protein contact site critical for signaling specificity and G protein activation. Proc Natl Acad Sci USA 92:11642-11646.
14. 2-adrenoceptor. Mol Pharmacol 48:316-325.
15. McKenzie FR and Milligan G (1990) Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2. Biochem J 267:391-398.
16. Ren Q, Kurose H, Lefkowitz RJ and Cotecchia S (1993) Constitutively active mutants of the alpha 2-adrenergic receptor. J Biol Chem 268:4625-4636.
17. 2-adrenergic receptor: Extending the ternary complex model. J Biol Chem 268:4625-4636.
18. Senogles SE (1994) The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase: A study with site-directed mutant Gi alpha proteins. J Biol Chem 269:23120-23127.
19. Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol 11:379-393.
20. Whaley BS, Yuan N, Birnbaumer L, Clark RB and Barber R (1994) Differential expression of the β-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: A quantitative evaluation. Mol Pharmacol 45:481-489.
21. i1α fusion protein. FEBS Lett 419:141-146.
22. i1α fusion protein. Biochem J 325:17-21.
23. i1α by expressing the proteins from chimaeric open reading frames. J Biol Chem 272:24673-24678.
24. Wise A, Watson-Koken MA, Rees S, Lee M and Milligan G (1997c) Interactions of the alpha2A-adrenoceptor with multiple Gi-family G-proteins: Studies with pertussis toxin-resistant G-protein mutants. Biochem J 321:721-728.
25. Yamaguchi I, Harmon SK, Todd RD and O' Malley KL (1997) The rat D4 dopamine receptor couples to cone transducin (Galpha t2) to inhibit forskolin-stimulated cAMP accumulation. J Biol Chem 272:16599-16602.